Results 81 to 90 of about 6,942 (191)

Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care

open access: yesTürkiye Parazitoloji Dergisi, 2022
Objective:Dihydroartemisinin-Piperaquine (DHP) combination is the first-line treatment for uncomplicated malaria in Indonesia and has been used since 2010.
Lambok Siahaan
doaj   +1 more source

Unveiling Antimalarial Drug Resistance: The Role of CRISPR‐Cas Technologies in Malaria Research

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Background Malaria, caused by Plasmodium parasites, remains a global health burden, with drug resistance threatening control efforts. CRISPR‐Cas technologies, particularly CRISPR‐Cas9, have transformed malaria research by enabling precise genetic manipulations to study antimalarial resistance mechanisms, develop novel therapeutics and enhance ...
Reuben Samson Dangana   +3 more
wiley   +1 more source

Malaria diagnosis under field conditions in the Venezuelan Amazon.

open access: yes, 2008
To improve practical, accurate diagnosis of malaria in the Amazon rainforest of Venezuela, two rapid diagnostic tests (RDT) (OptiMAL-IT) and FalciVax) and a laboratory light microscope, used in the field with a battery-operated head lamp as an external ...
Fanello, C. I.   +15 more
core   +1 more source

Potential Role of ACE Polymorphisms in Severe Malaria: A Case Report

open access: yesCase Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
Malaria, primarily caused by Plasmodium falciparum, remains a critical global health challenge, particularly in sub‐Saharan Africa. Genetic factors such as angiotensin‐converting enzyme (ACE) I/D polymorphism have been implicated in influencing malaria severity and outcomes.
Raffaella Pisapia   +5 more
wiley   +1 more source

Simultaneous identification of species and molecular forms of the Anopheles gambiae complex by PCR-RFLP.

open access: yes, 2002
For differential identification of sibling species in the Anopheles gambiae Giles complex (Diptera: Culicidae), including simultaneous separation of M and S molecular forms within An. gambiae Giles sensu stricto, we describe a PCR-RFLP method.
SANTOLAMAZZA, FEDERICA   +9 more
core   +1 more source

Antimalarial Activity and Safety Profile of Gaysorn‐Tang‐Ha (GSTH): A Thai Herbal Recipe Evaluated in an ICR Model

open access: yesScientifica, Volume 2026, Issue 1, 2026.
Natural compounds have gained considerable attention in the search for novel therapeutic agents, particularly for infectious diseases such as malaria. Traditional herbal medicines offer promising alternatives to address the growing challenge of drug‐resistant Plasmodium strains.
Arisara Phuwajaroanpong   +7 more
wiley   +1 more source

The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment.

open access: yes, 2006
and is the largest organisation operating with a mission to reduce poverty worldwide. Malaria destroys about 1 million lives a year; the disease is the leading parasitic cause of death for Africa’s children and impoverishment for their families.
Sibley, CH   +55 more
core   +1 more source

Treatment Failure and Post‐Artesunate Delayed Haemolysis in a Returned Traveller From Uganda With Partially Drug‐Resistant Severe Plasmodium falciparum Malaria

open access: yesMedical Journal of Australia, Volume 224, Issue 1, January 2026.
ABSTRACT A man aged in his 40s, recently returned from Uganda, was hospitalised with Plasmodium falciparum malaria, with hyperparasitaemia of ~1.5 × 106 parasites/μL (26%). He received intravenous artesunate followed by artemether–lumefantrine. However, parasite clearance was delayed, and despite a negative blood film following treatment, the patient ...
Jye Travis   +6 more
wiley   +1 more source

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy

open access: yesPLoS ONE, 2014
Artemisinin combination therapy (ACT) is recommended for the treatment of multidrug resistant malaria in the second and third trimesters of pregnancy, but the experience with ACTs is limited. We review the exposure of pregnant women to the combination dihydroartemisinin-piperaquine over a 6 year period.From April 2004-June 2009, a prospective hospital ...
Poespoprodjo, JR   +7 more
openaire   +5 more sources

Reimagining Social Value to Consider the Environment: How Should We Judge the Magnitude of Benefits in Health Research?

open access: yesBioethics, Volume 39, Issue 9, Page 821-833, November 2025.
ABSTRACT Growing recognition of intersections between our health and the environment, healthcare systems and the environment, and health research and the environment has led bioethics scholars to advocate that the field readopt a broader perspective that considers nature.
Bridget Pratt, Rieke van der Graaf
wiley   +1 more source

Home - About - Disclaimer - Privacy